About Ollin Biosciences
Ollin Biosciences is a private company based in Austin, Texas, incorporated in 2022 in Delaware. It has reported $156,249,990 raised in one offering on Form D since June 2026. Its chief executive is Jason Ehrlich.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 14, 2026 | Jun 24, 2026 | $156,249,990of $330.0M target | 32 | $4.8M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ollin Biosciences's Form D filed Jun 24, 2026.